PPAR inhibitor, Leriglitazone, Purity ≥98%

Synonym: 146062-44-4; Hydroxypioglitazone; Leriglitazone; Hydroxy pioglitazone (M-IV); 5-[[4-[2-[5-(1-Hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

CAS Number: 146062-44-4
Compound CID: 4147757

Product Size

1 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Leriglitazone is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting PPAR.

Molecular Weight

372.44

Molecular Formula

C₁₉H₂₀N₂O₄S

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Applications

Leriglitazone is a metabolism inhibitor that can be used for its ability to improve insulin sensitivity and glucose regulation with potentially fewer side effects compared to other PPARγ agonists.